These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 33552062)

  • 21. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
    Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
    Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY; Wen MC
    Ann Rheum Dis; 2004 Oct; 63(10):1300-6. PubMed ID: 15361391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.
    Colafrancesco S; Priori R; Alessandri C; Astorri E; Perricone C; Blank M; Agmon-Levin N; Shoenfeld Y; Valesini G
    Immunol Res; 2014 Dec; 60(2-3):177-83. PubMed ID: 25388964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current concepts on the physiopathology of adult-onset Still's disease].
    Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC
    Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
    Bindoli S; Galozzi P; Doria A; Sfriso P
    Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of adult onset still's disease: current understanding and new insights.
    Ruscitti P; Giacomelli R
    Expert Rev Clin Immunol; 2018 Nov; 14(11):965-976. PubMed ID: 30295095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
    Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
    Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.
    Shimojima Y; Kishida D; Ueno KI; Ushiyama S; Ichikawa T; Sekijima Y
    J Rheumatol; 2019 Oct; 46(10):1268-1276. PubMed ID: 30770498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.
    Ruscitti P; Ciccia F; Cipriani P; Guggino G; Di Benedetto P; Rizzo A; Liakouli V; Berardicurti O; Carubbi F; Triolo G; Giacomelli R
    Clin Exp Immunol; 2016 Mar; 183(3):397-404. PubMed ID: 26540556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
    Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
    J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
    Colafrancesco S; Alessandri C; Conti F; Priori R
    Autoimmun Rev; 2020 Jul; 19(7):102573. PubMed ID: 32387470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
    Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
    Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome.
    Coffernils M; Soupart A; Pradier O; Feremans W; Nève P; Decaux G
    J Rheumatol; 1992 Sep; 19(9):1425-7. PubMed ID: 1433011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.
    Chen PK; Chen DY
    J Immunol Res; 2021; 2021():8998358. PubMed ID: 34239943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
    Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
    Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
    Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
    J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.